Home › Free Stock Grades › BIIB
Biogen Inc. (BIIB) Stock Grade
BIIB · Healthcare
B
Market Cap
$33.8B
P/E Ratio
20.0
Revenue Growth (YoY)
+1.4%
Net Margin
13.2%
Return on Equity
7.1%
Dividend Yield
None
About Biogen Inc.'s fundamentals
Biogen is a large-cap pharmaceutical company with a market capitalization of $32.7 billion, trading at a P/E ratio of 20.0 relative to earnings. The company is growing modestly, with revenue increasing 1.4% year-over-year, while maintaining a net profit margin of 13.2%. Return on equity stands at 7.1%, indicating relatively modest efficiency in generating returns from shareholder capital, and the company does not currently pay a dividend.